Journal Home
Search for

Volume 17, Issue 7, Pages 540-547 (June 2010)


View previous. 10 of 11 View next.

Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp. shows potent anti-retroviral activity in vitro

Charles O. EsimoneaceCorresponding Author Informationemail address, Gero Eckb, Chukwuemeka S. Nworuad, Dennis Hoffmanna, Klaus Überlaa, Peter Prokschb

published online 07 December 2009.

Abstract 

Screening of a panel of purified compounds isolated from Aglaia sp. (Meliaceae) for inhibition of early steps in the lentiviral replication cycle led to the identification of the 3, 4-secodammarane triterpenoid, ignT1, which inhibited HIV-1 infection potently (IC50=0.48μg/ml), while cytotoxic effects and inhibition of cell proliferation were only observed at concentrations exceeding 10.69μg/ml. Time of addition experiments revealed similar kinetics to the non-nucleoside RT-inhibitor (NNRTI), Nevirapine, although the latter was significantly less cytotoxic. However, unlike Nevirapine, dammarenolic acid also potently inhibited the in vitro replication of other retroviruses, including Simian immunodeficiency virus and Murine leukemic virus in vector-based antiviral screening studies. Interestingly, the methyl ester analogue of dammarenolic acid-methyldammarenolate had no anti-HIV-1 activity. Cell cycle analysis revealed that ignT1 arrests HeLa cells at the S and G2/M phase. These results strongly suggest that dammarenolic acid could be a promising lead compound for the development of novel anti-retrovirals.

a Department of Molecular and Medical Virology, Ruhr-University Bochum, Germany

b Institutes for Pharmaceutical Biology, Heinrich-Heine-University Düsseldorf, Germany

c Department of Pharmaceutics and Pharmaceutical Microbiology, University of Nigeria, Nsukka, Enugu State, Nigeria

d Department of Pharmacology and Toxicology, University of Nigeria, Nsukka, Enugu State, Nigeria

e Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University Awka, Anambra State, Nigeria

Corresponding Author InformationCorresponding author at: Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University Awka, Anambra State, Nigeria. Tel.: +2348062835781.

PII: S0944-7113(09)00270-0

doi:10.1016/j.phymed.2009.10.015


View previous. 10 of 11 View next.